Jan Hillson

Jan Hillson

Director/Board Member at ELEDON PHARMACEUTICALS, INC.

Net worth: - $ as of 2026-05-30

73 year
Health Technology
Consumer Services
Health Services

Profile

Jan L.
Hillson
is currently an Independent Director at Eledon Pharmaceuticals, Inc. since 2021 and a Partner at Cascadia Drug Development Group LLC starting in 2024.
Former roles include Senior Vice President-Clinical Development at Provention Bio, Inc. from 2021 to 2024, Senior Vice President-Clinical Development at Alpine Immune Sciences, Inc. from 2019 to 2021, Senior Vice President-Drug Development at ChemoCentryx, Inc. from 2016 to 2019, Vice President-Clinical & Translational Research at Momenta Pharmaceuticals, Inc. from 2013 to 2016, Senior Director at ZymoGenetics, Inc. from 2007 to 2013, Medical Director at Xcyte Therapies, Inc., Assistant Professor at the University of Washington, Division Head at Virginia Mason Medical Center, Chief Medical Officer at GlycoEra AG, and Member-Clinical Faculty at Harvard Medical School.
Education includes undergraduate studies at Michigan State University, graduate degrees from California Institute of Technology and Scripps Institution of Oceanography, and a doctorate from Stanford University School of Medicine.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-03-30 0 ( -.--% ) - $ 2026-05-30

Jan Hillson active positions

CompaniesPositionStart
ELEDON PHARMACEUTICALS, INC. Director/Board Member 2021-07-01
Corporate Officer/Principal 2024-01-31

Former positions of Jan Hillson

CompaniesPositionEnd
PROVENTION BIO, INC. Corporate Officer/Principal 2024-01-31
ALPINE IMMUNE SCIENCES, INC. Chief Tech/Sci/R&D Officer 2021-10-31
CHEMOCENTRYX, INC. Corporate Officer/Principal 2019-05-31
MOMENTA PHARMACEUTICALS, INC. Chief Tech/Sci/R&D Officer 2015-12-31
Corporate Officer/Principal 2012-12-31
See the detail of Jan Hillson's experience

Training of Jan Hillson

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

52

1st degree connections

16

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies16

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Services

Consumer Services

Consumer Services

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services